Suicide Prevention - Case Studies

SUICIDE PREVENTION CASE STUDIES

Overview & Clinical Scope

Suicidality demands rapid clinical recognition, accurate risk stratification, and structured evidence-based interventions. While theoretical knowledge lays the foundation, real-world presentation often involves layered complexities—such as acute environmental stressors, psychiatric comorbidities, and substance misuse—that require nuanced, compassionate clinical decision-making.

On this page, we present a series of detailed video case studies derived from the lecture titled “Suicide – Why Do It?”Designed for both live seminar training and independent clinical study, these cases examine the practical application of risk assessment, immediate safety planning, crisis de-escalation, and multidisciplinary management across diverse patient presentations.

Interactive Case Studies

Case Study 1: History of Suicide Attempts

Longitudinal case study tracing a patient over several months to illustrate depressive onset, subtle mental state changes, and relapse indicators.

Clinical Commentary

Most professionals in psychiatry find suicide risk management deeply challenging. There is often an unwritten expectation that all suicide attempts are avoidable and that a completed suicide represents a failure of care. The latest UK figures are available here. The Office for National Statistics (ONS) and NHS Digital compile current UK mortality datasets annually.

Suicide is associated with severe mental illness but is not a clinical diagnosis in itself; it shares significant diagnostic overlap with Deliberate Self-Harm (DSH).

Case Evolution: This video features clips from clinical interviews conducted over several months. The primary working diagnosis is Major Depressive Disorder.
Key Mental State Finding: In the initial interview, the patient did not recognise that she was depressed—underscoring the vital role of a thorough Mental State Examination (MSE) over self-report.
Relapse Indicators: Although her mood appeared brighter in middle interviews while receiving community support, the final clip reveals subtle pointers toward relapse, including social withdrawal and affective flattening.
Clinical Takeaway: Continuity of care and ongoing longitudinal monitoring are critical; an improved mood presentation can sometimes mask underlying deterioration.

Case Study 2: First Attempt & Self-Medication

Examination of substance misuse as a maladaptive coping mechanism and the hidden suicide risks during inpatient detox.

Clinical Commentary

Substance misuse and addiction frequently mask underlying psychiatric distress or act as maladaptive responses to chronic unhappiness. Patients often use alcohol or drugs to self-medicate symptoms they cannot fully articulate or recognise.

Case Evolution: This case explores the complex interplay between addiction and mood disorders. While standard inpatient detoxification followed by aftercare leads to recovery for many, bio-psycho-social variables heavily dictate outcomes.
The Vulnerability Trap: In this patient’s case, a simple detox intervention was insufficient. Stripping away the addiction without addressing the underlying trauma exposed her to severe emotional vulnerability, as the substance had previously functioned as a psychological defence mechanism against profound despair.

Case Study 3: Was I Depressed for Longer? (Bereavement & Grief)

Differentiating reactive major depression from severe, unresolvable grief following complex bereavement.

Clinical Commentary

Bereavement is a major life event and a potent risk factor for both physical and mental ill-health. However, Case 3 is most accurately conceptualised as a complex, unresolvable grief presentation.

Diagnostic Differentiation: While the patient exhibits features of reactive depression, her cognitive focus is dominated by unresolved grief rather than primary mood dysfunction.
Clinical Takeaway: Practitioners must distinguish between complicated grief and major depressive episodes to tailor effective psychotherapeutic and safety interventions.

Lecture Companion Notes: "Suicide – Why Do It?"

Target Audience: Medical students, junior medical staff, and specialist healthcare professionals (UK Clinical Practice).

Epidemiology & Public Health Impact (ONS & NHS Data)

According to data from the Office for National Statistics (ONS) and NHS Digital:

Mortality Rank: Suicide is among the top 10 leading causes of death worldwide. In the UK, it ranks 3rd in total years of life lost, behind coronary heart disease and cancer.
Demographic Peak: Suicide accounts for ~1% of all UK deaths. In young males (under 35), it represents the second most common cause of death after accidental injury.
Deliberate Self-Harm (DSH) Risk: Suicide rates in the 12 months following an episode of DSH are 100 times higher than in the general population.
Post-Discharge Period: The period immediately following discharge from inpatient psychiatric care carries a significantly heightened risk of suicide.

The Act & Aetiology of Suicide Methods of Suicide (UK vs. International Data)

UK (England & Wales): Self-poisoning/car exhaust fumes (33% in men), Hanging (28% in men), Drug Overdose (~50% in women).
International (USA): Firearms and violent methods predominate.
Planning: Most completed suicides involve anticipatory planning and precautions against discovery. However, warning signs or explicit communications occur in most cases.

Psychiatric Co-morbidities & Risk Factors

Condition / Factor

Estimated Lifetime / Relative Risk

Key Clinical Risk Identifiers

Personality Disorders

Present in 33% – 50% of completed suicides

Impulsivity, emotional dysregulation, aggression

Mood Disorders

~6% lifetime suicide mortality

Older age, male, living alone, severe insomnia, hopelessness

Alcohol Misuse

~7% lifetime suicide mortality

Co-occurring depression, recent heavy drinking, social isolation

Schizophrenia

4% – 10% lifetime suicide mortality

Male, young, early illness stage, post-discharge (within 6 months), akathisia

Postnatal Period

Lower overall suicide rate

Note: Protective effect despite higher overall psychiatric morbidity

Risk Stratification & Clinical Hazards

Socio-Demographic High-Risk Profile

Elderly age group
Male gender
Divorced, widowed, or single status
Unemployed or retired
Living alone
Chronic physical illness
History of mood disorders, addiction, or suicide
Early childhood bereavement
Early childhood bereavement
Social Class I and V

⚠️ Hazards That Mislead Risk Assessment

Deliberate denial of suicidal ideation during assessment.
Rapid clinical improvement resulting merely from hospital admission (removal of environmental stressor) while core issues remain unresolved.
Fluctuating distress levels between interviews.
Malignant alienation: Staff frustration or antagonism toward difficult/uncooperative patients leading clinicians to dismiss threats as “empty manipulation.”

Management & Immediate Actions

💡 Clinical Rule of Thumb: The assessment of suicidal intent is inherently complex—always err on the side of caution. Brief admission to a place of safety allows for stabilization and a multi-disciplinary formulation.

Environmental & Protocol Precautions: Ensure close monitoring during high-risk windows (shift changes, bank holidays, immediate post-admission, and early leave).
Safety & Crisis Planning: Establish clear, written fall-back plans for the patient, involving Crisis Resolution and Home Treatment Teams (CRHT) or Community Mental Health Teams (CMHT).
Setting Limits with Compassionate Care: Balance structured behavioral boundaries with strong therapeutic alliance, avoiding punitive discharge decisions during crises.

Key Clinical Learning Points:

Mental State Examination (MSE) over Self-Report: As seen in Case 1, patients may not recognize or articulate their own depression; formal MSE skills are vital for accurate formulation.
Detox Vulnerability: Removing a substance without addressing core psychological pain can strip away a coping mechanism, temporarily increasing suicide vulnerability (Case 2).
Grief vs. Reactive Depression: Unresolvable grief can dominate clinical presentation; distinguishing complicated bereavement from primary mood disorders dictates the treatment pathway (Case 3).
Continuity of Care: A brighter affect does not equal resolution; ongoing longitudinal monitoring is essential to catch subtle signs of relapse.

Seminar & Reflective Discussion Questions

Reflecting on Case 1, how would you approach a patient whose subjective mood report conflicts directly with your objective MSE findings?
In Case 2, what multi-disciplinary safety nets should be established prior to discharging a patient from an inpatient detoxification unit?
How do clinical teams maintain a compassionate therapeutic alliance without succumbing to ‘malignant alienation’ when managing high-risk, challenging presentations?

Information & Support for Patients & Public Viewers

If you or someone you know is in distress or immediate danger:

NHS Urgent Mental Health Services: Find your local NHS 24/7 urgent mental health helpline via nhs.uk/urgentmentalhealth.
Samaritans: Call 116 123 (Free 24/7 UK helpline) or email jo@samaritans.org.
Shout Crisis Text Line: Text SHOUT to 85258 for free 24/7 text support.
Emergency Services: Call 999 or go to your nearest A&E department.

Add Your Heading Text Here

Clinical & Educational Disclaimer

This platform and associated video case studies are intended solely for clinical education, medical training, and professional development for healthcare practitioners and trainees. Case study material has been anonymized and structured for live and digital lecture delivery. This content does not constitute formal clinical advice or replace emergency psychiatric evaluation.